Quantum BioPharma Q4 EPS $(0.71) Beats $(0.93) Estimate

Quantum BioPharma (NASDAQ: QNTM) reported a Q4 loss of $(0.71) per share, which exceeded the analyst estimate of $(0.93) by 23.66%. This represents a 65.53% improvement compared to losses of $(2.06) per share in the same quarter last year.